From £7.99 per month
ShareProphets
The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares

MINDING THE LSE’S BUSINESS

Join for as low as £7.99 per month

With ShareProphets’ membership, you receive:

• All premium articles

• Tom Winnifrith’s Bearcast

• Access to all the entire nearly 10 year archive

• ShareProphets Daily Newsletter

Eddie Stobart shares suspended, dividend under review, accounting probe, CEO "resigned" – more disastrous news for Neil Woodford

By Nigel Somerville, the Deputy Sheriff of AIM | Friday 23 August 2019


Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.


It never rains when it pours for Neil Woodford. This morning we were told that his investment into the breaking of the laws of physics has been revalued downwards and at 7.30am we learnt that shares in AIM-listed Eddie Stobart (ESL) have been suspended, the accounts will be late, the dividend is under review (ie going to be chopped) and the CEO has walked (ie been pushed). This is all in relation to an audit review. Apart from that everything is fine…..oh, apart from the profit warning – and dear old Neil's funds holds 22.89% of the company, as at 2 August worth, at last night's close, £62 million. Oh Dear.

Premium content is for paid subscribers only
ShareProphets is reader-supported journalism

Become a member starting at £6.99 per month for all articles, the Bearcast, and our seven year archive.


Filed under:



Subscribe to our newsletter

Daily digest of our latest stories.



Search ShareProphets

Market News

Complete Coverage

Recent Comments

That Was the Week that Was

 

AAU

Gold up Ariana down

Saturday »

AVCT

Cassava, A warning to Avacta Sharehoders 

Friday »

ALU

Alumasc Group – a growth Buy

 

VCP

Victoria - The roll up unravels

 

HEMO

Hemogenyx is a short – target 0p

 

ECR

ECR, the timing is unfortunate

Time left: 01:45:16